Novartis Aktie
98,72
EUR
-0,68
EUR
-0,68
%
91,55
CHF
-0,74
CHF
-0,80
%
Werbung
Novartis Aktie Analyse
02.02.22 | Novartis Market-Perform | Bernstein Research | |
02.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
02.02.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
02.02.22 | Novartis Underweight | Barclays Capital | |
02.02.22 | Novartis Buy | Jefferies & Company Inc. | |
01.02.22 | Novartis Underweight | JP Morgan Chase & Co. | |
31.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
31.01.22 | Novartis Underweight | Barclays Capital | |
Werbung
|
|||
25.01.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
20.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
14.01.22 | Novartis Equal-weight | Morgan Stanley | |
12.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
07.01.22 | Novartis Neutral | UBS AG | |
04.01.22 | Novartis Underweight | JP Morgan Chase & Co. | |
23.12.21 | Novartis Buy | Jefferies & Company Inc. | |
23.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
20.12.21 | Novartis Buy | Jefferies & Company Inc. | |
20.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
17.12.21 | Novartis Sell | Deutsche Bank AG | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
16.12.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.21 | Novartis Buy | Jefferies & Company Inc. | |
14.12.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.12.21 | Novartis Neutral | Credit Suisse Group | |
07.12.21 | Novartis Buy | Jefferies & Company Inc. | |
06.12.21 | Novartis Sell | Deutsche Bank AG | |
03.12.21 | Novartis Neutral | UBS AG | |
03.12.21 | Novartis Underweight | JP Morgan Chase & Co. | |
26.11.21 | Novartis Neutral | UBS AG | |
11.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
10.11.21 | Novartis Buy | Jefferies & Company Inc. | |
05.11.21 | Novartis Neutral | UBS AG | |
04.11.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.10.21 | Novartis Underweight | Barclays Capital | |
27.10.21 | Novartis Sell | Deutsche Bank AG | |
27.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.10.21 | Novartis Neutral | Credit Suisse Group | |
26.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
26.10.21 | Novartis Buy | UBS AG | |
26.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
26.10.21 | Novartis Sell | Deutsche Bank AG | |
25.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
25.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
25.10.21 | Novartis Buy | UBS AG | |
14.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
12.10.21 | Novartis Market-Perform | Bernstein Research | |
11.10.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.10.21 | Novartis Buy | UBS AG |
Werbung
Werbung